No Data
No Data
Inhibikase Therapeutics Advances PAH Treatment With New Leadership
Inhibikase Names McIntyre Finance Chief as Lees-Rolfe Resigns
Press Release: Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer
Hedge Funds Owners May Consider Drastic Measures as Inhibikase Therapeutics, Inc.'s (NASDAQ:IKT) Recent US$29m Drop Adds to Long-term Losses
H.C. Wainwright Maintains Inhibikase Therapeutics(IKT.US) With Hold Rating
Express News | HC Wainwright & Co. Reiterates Neutral on Inhibikase Therapeuticsto Neutral